The Triple Effect Of Community Based Clinical Trials

Clinical trial success depends on more than enrollment alone. Sponsors must also ensure participants remain engaged throughout the study while generating data that accurately reflects the populations most affected by disease. Community-based clinical trials (CBCTs) offer a practical approach to addressing all three challenges simultaneously by bringing research closer to where patients live.
When trial participation becomes more accessible, patients face fewer logistical barriers, reducing the risk of dropout and helping studies stay on schedule. Local trial sites also foster stronger connections between participants and research teams, creating opportunities for richer patient insights and more consistent engagement over time. At the same time, placing research within communities expands access to broader and more representative populations, helping sponsors capture the diverse, real-world data increasingly valued by regulators and stakeholders. Together, these benefits create a powerful "triple effect": faster enrollment, improved retention, and more complete datasets.
Discover how community-based research models are reshaping clinical trial execution and helping organizations improve performance across critical study metric
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.